Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02873273 · ClinicalTrials.gov registry record · Phase 1
Study of a Steroid Delivery System for Pain Relief Treatment in Patients With Knee Osteoarthritis
A Phase 1 study of Osteoarthritis, Knee, sponsored by Mark Figgie.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT02873273: Completed Phase 1 study of Osteoarthritis, Knee, sponsored by Mark Figgie.
NCT02873273 is a Phase 1 study of Osteoarthritis, Knee that has completed, run by Mark Figgie. The registered enrollment target is 6 participants, below the 498-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02873273, a Phase 1 study of Osteoarthritis, Knee, has completed, sponsored by Mark Figgie.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether a longer duration, controlled, sustained release dexamethasone delivery system would be more effective in helping patients with osteoarthritis reduce their pain, remain functional, and delay their need for knee replacement.
Conditions Studied
Interventions
- DRUG Dexamethasone
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2016-10-14 |
| Est. Completion | 2017-09-21 |
| Phase | Phase 1 |
What the finished NCT02873273 record still lists
NCT02873273 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 498-participant average among 112 other Osteoarthritis, Knee trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Osteoarthritis, Knee appearing as the primary indexed condition, and to 1 intervention - of which Dexamethasone is the first listed.
NCT02873273 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02873273 about?
NCT02873273 is a clinical study titled "Study of a Steroid Delivery System for Pain Relief Treatment in Patients With Knee Osteoarthritis". The purpose of this study is to determine whether a longer duration, controlled, sustained release dexamethasone delivery system would be more effective in helping patients with osteoarthritis reduce their pain, remain functional, and delay their need for knee replacement.
What is the current status of trial NCT02873273?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2016-10-14. Estimated completion is 2017-09-21.
What conditions does trial NCT02873273 study?
This clinical trial studies the following conditions: Osteoarthritis, Knee.
What interventions are being tested in trial NCT02873273?
The interventions under investigation include: Dexamethasone (DRUG).
Who is sponsoring clinical trial NCT02873273?
This trial is sponsored by Mark Figgie, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02873273 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02873273's enrollment target sits among peer trials
6 113th of 112 the lowest of 112 other Osteoarthritis, Knee trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
CBD for Knee Osteoarthritis
RECRUITING · Phase 1
-
Oral Steroid Taper After Total Knee Arthroplasty
RECRUITING · Phase 1
-
The Role of Vitamin K on Knee Osteoarthritis Outcomes
RECRUITING · Phase 1
-
Safety and Pharmacodynamics of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
ACTIVE NOT RECRUITING · Phase 1
-
Prospective Evaluation of PRP and BMC Treatment to Accelerate Healing After ACL Reconstruction
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI